These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 12476869)
1. Formulation and stability evaluation of ketoprofen sustained-release tablets prepared by fluid bed granulation with Carbopol 971P solution. Vaithiyalingam SR; Tuliani P; Wilber W; Reddy IK; Khan MA Drug Dev Ind Pharm; 2002 Nov; 28(10):1231-40. PubMed ID: 12476869 [TBL] [Abstract][Full Text] [Related]
3. [A comparative analysis of the influence of different types of Carbopol on the release rate of lithium-carbonate from matrix tablets]. Toskić-Radojcić M; Pavlović M; Gazikalović E; Arandjelović A; Kovacević A Vojnosanit Pregl; 2012 Aug; 69(8):675-80. PubMed ID: 22924263 [TBL] [Abstract][Full Text] [Related]
4. Surfactant-Assisted Wet Granulation-Based Matrix Tablets without Exceptional Additives: Prolonging Systemic Exposure of Model BCS Class II Ketoprofen. Shamim R; Shafique S; Hussain K; Abbas N; Ijaz S; Bukhari NI AAPS PharmSciTech; 2024 Oct; 25(7):241. PubMed ID: 39402222 [TBL] [Abstract][Full Text] [Related]
5. A new approach for preparing a controlled release ketoprofen tablets by using beeswax. Uner M; Gönüllü U; Yener G; Altinkurt T Farmaco; 2005 Jan; 60(1):27-31. PubMed ID: 15652365 [TBL] [Abstract][Full Text] [Related]
6. Exploratory studies in heat-assisted continuous twin-screw dry granulation: A novel alternative technique to conventional dry granulation. Kallakunta VR; Patil H; Tiwari R; Ye X; Upadhye S; Vladyka RS; Sarabu S; Kim DW; Bandari S; Repka MA Int J Pharm; 2019 Jan; 555():380-393. PubMed ID: 30458256 [TBL] [Abstract][Full Text] [Related]
7. Effects of formulation and process variables on the release of a weakly basic drug from single unit extended release formulations. Kranz H; Wagner T Eur J Pharm Biopharm; 2006 Jan; 62(1):70-6. PubMed ID: 16154330 [TBL] [Abstract][Full Text] [Related]
8. Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations. Korang-Yeboah M; Rahman Z; Shah D; Mohammad A; Wu S; Siddiqui A; Khan MA Int J Pharm; 2016 Feb; 499(1-2):20-28. PubMed ID: 26688036 [TBL] [Abstract][Full Text] [Related]
9. Formulation optimization, in vitro characterization and stability studies of sustain release tablets of Ketoprofen. Hafeez A; Razvi N; Talib N; Ghayas S; Anjum F; Bushra R Pak J Pharm Sci; 2019 May; 32(3 (Supplementary)):1245-1251. PubMed ID: 31303597 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of drug physical form during granulation, tabletting and storage. Williams AC; Cooper VB; Thomas L; Griffith LJ; Petts CR; Booth SW Int J Pharm; 2004 May; 275(1-2):29-39. PubMed ID: 15081136 [TBL] [Abstract][Full Text] [Related]
11. Effect of formulation and process variables on the release behavior of amoxicillin matrix tablets. Tapia-Albarran M; Villafuerte-Robles L Drug Dev Ind Pharm; 2004 Sep; 30(8):901-8. PubMed ID: 15521335 [TBL] [Abstract][Full Text] [Related]
12. Accelerated stability of Ibuprofen-Eudragit RSPM sustained release tablets, IR and DSC solid stability testing. Abdel Rahman AA; Aboutaleb AE; Stamm A; Samy EM; Abdel-Rahman SI J Pharm Belg; 1993; 48(6):463-70. PubMed ID: 8133428 [TBL] [Abstract][Full Text] [Related]
13. Formulation and In-vitro Characterization of Sustained Release Matrix Type Ocular Timolol Maleate Mini-Tablet. Mortazavi SA; Jafariazar Z; Ghadjahani Y; Mahmoodi H; Mehtarpour F Iran J Pharm Res; 2014; 13(1):19-27. PubMed ID: 24734053 [TBL] [Abstract][Full Text] [Related]
14. Incidence of drying on microstructure and drug release profiles from tablets of MCC-lactose-Carbopol and MCC-dicalcium phosphate-Carbopol pellets. Gómez-Carracedo A; Souto C; Marti Nez-Pacheco R; Concheiro A; Gómez-Amoza JL Eur J Pharm Biopharm; 2008 Jun; 69(2):675-85. PubMed ID: 18248805 [TBL] [Abstract][Full Text] [Related]
15. Formulation and in vitro evaluation of ibuprofen-Carbopol 974P-NF controlled release matrix tablets. III: Influence of co-excipients on release rate of the drug. Khan GM; Jiabi Z J Control Release; 1998 Jul; 54(2):185-90. PubMed ID: 9724905 [TBL] [Abstract][Full Text] [Related]
16. Effect of processing and formulation variables on the stability of a salt of a weakly basic drug candidate. Badawy S; Vickery R; Shah K; Hussain M Pharm Dev Technol; 2004 Aug; 9(3):239-45. PubMed ID: 15458230 [TBL] [Abstract][Full Text] [Related]
17. Studies on drug release kinetics from ibuprofen-carbomer hydrophilic matrix tablets: influence of co-excipients on release rate of the drug. Khan GM; Zhu JB J Control Release; 1999 Feb; 57(2):197-203. PubMed ID: 9971903 [TBL] [Abstract][Full Text] [Related]
18. Potential Use of Polyvinyl Acetate-Polyvinylpyrrolidone Mixture for the Development of Atenolol Sustained Release Matrix Tablets: Optimization of Formulation through in Vitro-in Vivo Assessment Study. Owayez AS; Abd El-Ghany GM; Abu Hashim II Chem Pharm Bull (Tokyo); 2017; 65(6):545-557. PubMed ID: 28566647 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of drug-excipient interaction in the formulation of celecoxib tablets. Bozdağ-Pehlivan S; Subaşi B; Vural I; Unlü N; Capan Y Acta Pol Pharm; 2011; 68(3):423-33. PubMed ID: 21648198 [TBL] [Abstract][Full Text] [Related]
20. Stability characterization of controlled release coprecipitates and solid dispersions. Khan MA; Karnachi AA; Agarwal V; Vaithiyalingam SR; Nazzal S; Reddy IK J Control Release; 2000 Jan; 63(1-2):1-6. PubMed ID: 10640575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]